These remarks have been edited for length and are being published in four parts. The following post is Part II of Neil M. Barofsky’s prepared remarks, which were delivered on July 28, 2020. For Part I of this post, click here.
My testimony concerning the effectiveness of the CARES Act will focus on the lending programs administered by the SBA, Treasury, and the Federal Reserve, with specific attention on the most active of these programs, the PPP. First, there is no question that the PPP has had a significant and positive impact on millions of small businesses, with a recent study by the Federal Reserve and others estimating that it helped preserve more than 2.3 million jobs.[1] But by no means should there be a declaration of mission accomplished. Chiefly, there has been a significant lack of transparency by Treasury and the SBA in the program that makes it difficult to fully assess its integrity, fairness (particularly to traditionally underbanked businesses), or overall effectiveness. In order to fully assess the program, additional measures will be needed to increase transparency and oversight. In addition, available information suggests that meaningful sums may have been lost or misdirected because the program design elevated the risk of fraud and misuse by borrowers.